20
Corden Pharma Bergamo Spa, based in Italy, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is MESALAMINE, with a corresponding US DMF Number 11807.
Remarkably, this DMF maintains an Active status since its submission on January 15, 1996, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of April 21, 2015, and payment made on October 22, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II